Skip to main navigation Skip to search Skip to main content

Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo study for healthy aging

  • Leocadio Rodríguez-Mañas
  • , Laure Carcaillon
  • , F. J. García-García
  • , J. A. F. Tresguerres
  • , G. Gutiérrez Avila
  • , R. Kireev

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)

Abstract

Adverse effects of higher endogenous estradiol (E2) levels on various clinical outcomes and on determinants of the frailty syndrome have recently been reported. However, there are no data about the potential relationship between E2 and frailty. We aimed to study the association between E2 levels and frailty among older postmenopausal women not taking hormonal therapy.
Original languageEnglish
Pages (from-to)2898-2906
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number8
DOIs
Publication statusPublished - 1 Aug 2012

Keywords

  • Frailty

Fingerprint

Dive into the research topics of 'Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo study for healthy aging'. Together they form a unique fingerprint.

Cite this